Fetal Penile Length and Corpus Cavernosum Length - Normal Measurement Via Ultrasound

The recruitment status of this study is unknown because the information has not been verified recently.

Verified April 2010 by Tel-Aviv Sourasky Medical Center. Recruitment status was Not yet recruiting

First Received on April 29, 2010. Last Updated on April 30, 2010 History of Changes

Sponsor:	Tel-Aviv Sourasky Medical Center
Information provided by:	Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:	NCT01114867

Purpose

Hypothesis: Measurement of fetal penis length by ultrasound may be inaccurate when measured from the scrotum to the penile tip. we will provide normal values of penile length measured from the penile tip to the abdominal wall and measuring the corpus cavernosum length.

Condition
Fetal Penis Length

Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	Prospective Cross-sectional Study of Fetal Penis and Corpus Cavernosum Length

Resource links provided by NLM:

MedlinePlus related topics: Ultrasound

U.S. FDA Resources

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Estimated Enrollment:	200
Study Start Date:	May 2010

Eligibility

Ages Eligible for Study:	14 Weeks to 34 Weeks
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Fetuses of healthy pregnant women

Criteria

Inclusion Criteria:

pregnant women at 14th through 34th week gestation,
routine ultrasound not preformed for anomalies at the genitourinary system,
estimated fetal weight corresponds to gestational age.

Exclusion Criteria:

women who's fetuses are suspected to be with fetal growth retardation,
women who's fetuses are suspected to be with genitourinary anomaly.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01114867

Locations

Israel
Ultrasound Unit in OBGYN, Soraski Medical Center	Not yet recruiting
Tel-Aviv, Israel, 64239
Contact: Yoseph Hartoov, Dr +972-3-6925747
Contact: Arnon Agmon, Dr +972-3-6925747 arnon@arnonagmon.com
Principal Investigator: Yoseph Hartoov, Dr

Sponsors and Collaborators

Tel-Aviv Sourasky Medical Center

Investigators

Principal Investigator:

Yoseph Hartoov, Dr

Tel-Aviv, Soraski Medical Center

More Information

No publications provided

Responsible Party:	Yoseph Hartoov / Dr, Sorasky Medical Center
ClinicalTrials.gov Identifier:	NCT01114867 History of Changes
Other Study ID Numbers:	TASMC-10-YH-0128-CTIL
Study First Received:	April 29, 2010
Last Updated:	April 30, 2010
Health Authority:	Israel: Ministry of Health

Keywords provided by Tel-Aviv Sourasky Medical Center:

ultrasound
penis length
corpus cavernosum
length of fetal penis and fetal corpus cavernosum

ClinicalTrials.gov processed this record on May 23, 2012